Pfizer Mini-Site

Pfizer is proud to be the Founding Sponsor of the AMGA’s Rise to Immunize® campaign and a collaborator focused on improving the rates of vaccination against respiratory disease in the United States.

Vaccine-preventable diseases can have a substantial impact on the health of individuals:

COVID-19: ~76,000 deaths among adults, 2023¹*
Pneumococcal pneumonia: Over 180,000 adult hospital admissions occur annually in the US, mostly in individuals aged ≥65 years,^2† with a 5-7% mortality rate that is higher in adults and those with underlying conditions³
Respiratory syncytial virus (RSV): ~6,000 to 10,000 deaths among older adults annually⁴

We are pleased to share the following resources to provide support for all those who are focused on reducing the impact of these illnesses. Please click on "VIEW RESOURCE" to view and download each item.

COVID-19 Resources

mRNA COVID-19 Vaccines Explained Infographic

The mRNA COVID-19 Vaccines Explained Infographic is a patient-focused one-sheet infographic created by Pfizer, along with BioNTech, and uses CDC information to help explain the science.

View Resource

Pneumococcal Pneumonia

US Adult HCP 50+ ACIP Recommendation Flashcard

The US Adult HCP 50+ ACIP Recommendation Flashcard details the recommendation for Pneumococcal vacccination in adults.

View Resource

Respiratory Syncytial Virus (RSV)

RSV Burden of Disease and Health System Resource

The RSV Burden of Disease and Health System Resource highlights the burden of RSV for patients in the hospital setting and reinforces the importance of vaccination in that setting.

View Resource

RSV Burden and Risk Factor Infographic

The Burden and Risk Factor Infographic focuses on the June 2024 ACIP Older Adult recommendation for RSV.

View Resource

Additional Resources About Vaccinations Against Respiratory Disease

Patient Screener Checklist

Certain medical conditions increase risk for some vaccine preventable diseases. This resource provides a checklist of vaccine preventable diseases impacted by comorbidities as well as age.

View Resource

AMGA Maternal Vaccine Preparedness QuIC Best Practice Guide

The AMGA Maternal Vaccine Preparedness QuIC Best Practice Guide introduces the AMGA Quality and Innovation Collective (QuIC), and shares collected insights from ten participating health systems who have prioritized maternal vaccinations.

View Resource

Maternal Vaccination Health System Readiness Toolkit

This toolkit features a variety of resources designed to support maternal vaccination preparedness at health systems.

View Resource

Wonder Literacy Video - Immune System

English language educational video on how immune system works in relation to vaccines.

View Resource

Wonder Literacy Video – Immune System - SPANISH

Spanish language educational video on how immune system works in relation to vaccines.

View Resource

Wonder Literacy Video - Vaccine Safety

English language educational video on the safety of vaccines.

View Resource

Wonder Literacy Video - Vaccine Safety - SPANISH

Spanish language educational video on the safety of vaccines.

View Resource

*Represents adults aged ≥25 years.¹

^†Hospitalizations recorded in the US based on 2019 census data.²

References

1. Ahmad FB, et al. MMWR Morb Mortal Wkly Rep. 2024;73(31):677-681.
2. Data on File. Pfizer Inc.
3. Centers for Disease Control and Prevention (CDC). Clinical Features of Pneumococcal Disease. Updated February 6, 2024.
Accessed December 1, 2024.
4. Havers FP, et al. JAMA Netw Open. 2024;7(11):e2444756.